2024-12-03 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Review

**1. Performance Comparison and Divergence:**

UnitedHealth Group Inc (UNH) is a diversified healthcare company offering a range of health benefits programs, insurance products, and health services.

The cumulative return of UNH is 211.88%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 130.06%. The difference is 81.8%, placing it at the 51.6th percentile of its historical performance relative to the S&P 500.  This indicates strong outperformance, although the relative strength is not consistently extreme based on historical comparisons.


**2. Recent Price Movement:**

* **Last Price:** 610.20
* **5-Day Moving Average:** 604.41
* **20-Day Moving Average:** 596.41
* **60-Day Moving Average:** 585.18

The price is above all three moving averages, suggesting a positive short-to-medium-term trend.  The relatively small gap between the 5-day and 20-day averages indicates a relatively stable recent price action.  The last market close of 606.34 is only slightly below the current price. No significant recent price jumps (sharp upward or downward movement) are indicated.


**3. Technical Indicators and Expected Return:**

* **RSI:** 47.45 -  Approaching the neutral zone (50), indicating neither overbought nor oversold conditions.
* **PPO:** 0.18 - Slightly positive, suggesting a bullish momentum.
* **20-Day Relative Divergence:**  `nan (-):`  This indicates a recent short-term downward trend in the relative strength of UNH against the S&P 500.
* **Expected Return:** 167.6% - This suggests a substantial long-term (2+ years) outperformance potential compared to the S&P 500, assuming continued historical trends.  However, this is a projection and not a guarantee.

**4. Recent Earnings Analysis:**

The provided earnings data shows some volatility.  While revenue generally increased, EPS fluctuated significantly. Notably:

* **Revenue Growth:**  Revenue has shown generally upward trending growth over the reported quarters, although the trend isn't perfectly linear.
* **EPS Trends:** EPS shows considerable variation between quarters, including a significant negative value in one quarter. This warrants further investigation into potential underlying causes.  Direct comparison of the duplicated 2024-11-04 data point is not possible without additional context.
* **Beats/Misses:**  The provided data doesn't include expectations; therefore, it's impossible to determine whether any quarter "beat" or "missed" analyst forecasts.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue is relatively stable, fluctuating around $98B. Profit margin shows some fluctuations but remains relatively high and mostly above 20%.
* **Capital and Profitability:**  Equity has increased, while ROE has been inconsistent, even showing negative values in one quarter. This inconsistency might indicate some cyclical trends within the company's operations or investment strategies.


**6. News and Recent Issues:**

No specific news or recent market outlook information is provided in the original prompt. Analyst opinions and performance highlights also require additional external data.


**7. Overall Analysis:**

UNH has historically significantly outperformed the S&P 500, with strong cumulative returns.  Recent price action is positive, though the 20-day relative divergence suggests a recent short-term weakening compared to the market.  Technical indicators are neutral to slightly bullish.  While revenue shows generally positive growth, earnings are inconsistent.  Financial information displays generally stable revenue but volatile profit margins and ROE.  The significant projected long-term outperformance potential needs further context and should be considered alongside other risks and market factors before making investment decisions.  Further investigation into the reasons for EPS volatility and the lack of contextual information regarding recent news and analyst opinions is highly recommended.


**8. Disclaimer:** This analysis is based solely on the provided data. It is not financial advice.  Independent research and consultation with a financial advisor are crucial before making any investment decisions.  The accuracy and completeness of the provided data have not been independently verified.
